Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 25, 2007
An in vivo and in vitro comparison of inhaled steroid delivery via a novel vortex actuator and a conventional valved holding chamberDaniel Menzies, Arun Nair, Tom Fardon, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
Targeting the small airways asthma phenotype: if we can reach it, should we treat it?Brian LipworthAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2025
Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptomsFraser Paterson, Jing Yuan On, Dania Ahmed, et al.Journal of Medical Case Reports|September 14, 2011
Aggregatibacter aphrophilus in a patient with recurrent empyema: a case reportLasantha Ratnayake, William J Olver, Tom FardonAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 20, 2023
Clinical impact of obesity on oscillometry lung mechanics in adults with asthmaRory Chan, Brian LipworthThe Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumabRory Chan, Brian LipworthAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 25, 2023
Efficacy of biologic therapy on airway hyperresponsiveness in asthmaRory Chan, Brian LipworthLung|June 6, 2022
Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and ExacerbationsRory Chan, Brian LipworthAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 21, 2021
Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthmaRory Chan, Brian LipworthDrug Safety|March 9, 2004
Benefit-risk assessment of long-acting beta2-agonists in asthmaCatherine M Jackson, Brian LipworthPageof 21